News

US FDA to Issue New Vouchers to Drug Developers to Shorten Review Time
(Reuters) -The U.S. Food and Drug Administration on Tuesday announced that it will issue a new priority review voucher to ...
US FDA to shorten review time for drug developers under new voucher program
The U.S. Food and Drug Administration said on Tuesday it is launching a program under which its commissioner can issue ...
We Spent a Year Investigating How the FDA Let Risky Drugs Into the U.S. Market
Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...
US FDA extends review of KalVista's swelling disorder drug due to heavy workload
KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a ...
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...
Kraft Heinz pulling certain artificial dyes from its US products in 2027
Kraft Heinz will be pulling certain artificial dyes from its U.S. products starting in 2027 and will no longer roll out new ...
Kraft Heinz says it will remove artificial dyes from its U.S. products by the end of 2027
Kraft Heinz said it will remove artificial dyes from its U.S. products by end of 2027 and stop making new products that ...
New FDA Chief Wants to Fast-Track Some Drugs, Use More AI
And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...
Bayer Files for FDA Approval of Gadoquatrane
The company's application included a submitted dose of 0.04 millimole gadolinium per kilogram of body weight. If approved, gadoquatrane would become the lowest dose macrocyclic gadolinium-based ...
Lab-Grown Salmon Gets FDA Approval
"Transparency is important to us at Wildtype." Wildtype is the third lab-grown meat producer to receive full government ...